Please login to the form below

Not currently logged in
Email:
Password:

Vifor Pharma appoints Dario Eklund

He takes on the role of head of international business operations

edit-Dario-EklundVifor Pharma has named Dario Eklund as their head of international business operations.

Eklund joins from Organogenesis, a regenerative medicine company which focuses in wound healing and soft tissue regeneration, where he was VP with responsibility for non-US operations, business development and licensing and the Gintuit business unit.

Prior to that, he was general manager of Switzerland for Aventis Pharma, until its 2004 merger with Sanofi, and earlier in his career he held a number of commercial and management roles for Novartis.

Eklund will report directly to Vifor Pharma CEO Søren Tulstrup and will be based at company's headquarters in Zurich, Switzerland.

Meanwhile, Vifor has also appointed Abdul Mullick to the position of head of global marketing. His previous roles include VP and general manager of endocrinology and cardiology in the rare diseases division of Sanofi in Boston, where he led the US and international operations.

18th September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics